More News! 28 Oct 2022 ‘Dark matter’ creates a whole new level of cancer gene activity in tumors, researchers say A whole new level of control of cancer gene activity within tumors, has been described by researchers as ‘dark matter’. It was recently discovered and published in two major studies… October 28, 2022 - 6 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Interview 29 Aug 2022 Making a success out of technology transfer at UCLB Having a good relationship with the technology transfer office at your university can be key to creating a successful startup. Anne Lane, CEO of University College London’s (UCL’s) commercialization company… August 29, 2022 - 13 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 15 Sep 2017 New British Biotech Enters the Clinic with Opioid Alternative for Chronic Pain Levicept’s Phase I study will test their new pain relief candidate’s safety and tolerability in healthy individuals and osteoarthritis patients. Levicept, based in Sandwich, UK, focuses on the development of… September 15, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 10 Jan 2024 The biggest private biotech investments in December 2023 The companies Tome Biosciences, Bicara Therapeutics, and Seismic Therapeutic bagged the biggest biotech investments in December 2023. Around the world, food, immunology, oncology, central nervous system (CNS), and biofermentation players… January 10, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 10 Sep 2019 Blood Test Increases Early Lung Cancer Diagnosis in UK Trial A blood test for anti-cancer antibodies, developed by the UK diagnostics company Oncimmune, detected more early cases of lung cancer than standard clinical monitoring procedures in a trial with more… September 10, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 28 Oct 2022 Beyond Biotech podcast 20: BioWin, eTherapeutics, CMT Research Foundation This week, we have three interviews, and four guests. We chatted with Keith Fargo, chief scientific officer at the CMT Research Foundation; François Colery, head of the Talent Now initiative… October 28, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 2 Nov 2022 CV6 Therapeutics raises $9.2M to test cancer drug CV6 Therapeutics has secured $9.2m to progress its lead oncology asset, CV6-168, into a first-in-human phase 1a clinical trial and perform further scientific development work. CV6 Therapeutics is a drug… November 2, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 29 Nov 2022 BioPharma Dynamics expands to provide more solutions for cell and gene therapy industry BioPharma Dynamics have expanded their portfolio for the cell and gene therapy market to offer a range of chemically defined T-Cell media, DMSO-free cryopreservation solutions, and recombinant growth factors. Suitable… November 29, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jan 2023 Cancer Research UK and Turbine to partner on program Cancer Research Horizons, the innovation engine at the core of the world’s largest private funder of cancer research, Cancer Research UK, has announced that it is partnering with Turbine AI,… January 5, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Interview 20 Feb 2017 Investment CEO shares Tips for Academics on Succeeding in Business With decades of experience, the CEO of Touchstone Innovations tells us about funding the development of academic projects into commercialized products Formerly known as Imperial Innovations, the investing arm of… February 20, 2017 - 7 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 27 Sep 2022 Watch: IntelliDigest using biotech to tackle food waste After obtaining a PhD in environmental engineering, Ifeyinwa Kanu set up IntelliDigest in 2016. Based in Edinburgh, Scotland, at the Heriot-Watt University Business School Incubator, the biotechnology company specializes in… September 27, 2022 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 28 Nov 2017 New Gene Therapy for Parkinson’s will be Developed in the UK Synpromics and UCL will collaborate to develop a gene therapy to treat Parkinson’s disease that only targets specific neurons involved in the disease. Synpromics, based in Edinburgh, Scotland, is a… November 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email